Mediastinal (N2) lymph node involvement is heterogeneous with huge variation in the extent and grouped together under stage IIIA. However, they showed a different survival even in the same stage. We tried to determine the prognostic implication of the multiple station N2 lymph node metastasis in stage IIIA N2 non-small cell lung cancer (NSCLC). The survival of stage IIIA N2 was analyzed according to the number of N2 station and their survival was compared with that of stage IIIB. In stage IIIA N2 NSCLC, multivariate analysis indicated that multiple station N2 was one of the independent prognostic factors for poor survival. The 5-yr survival of multiple station N2 IIIA (20.4%) was lower than that of single station N2 IIIA (33.8%) significant...
AbstractBackground: The number of N2 stations (single vs multiple N2 stations) is an important progn...
Patients with stage IIIA-ipsilateral mediastinal lymph node involvement (N2) non–small cell lung can...
Currently the most important prognostic factor in lung cancer is the stage. In the current lung TNM ...
To clarify the prognostic implication of the location and number of the metastatic mediastinal nodes...
Patients with non-small cell lung cancer (NSCLC) with metastases to ipsilateral mediastinal lymph no...
AbstractBackground: Clinical trials dealing with multimodal strategy for N2 non–small cell lung canc...
STUDY OBJECTIVES: Accurate TNM staging is the basis to evaluate prognosis and to plan treatment of p...
AbstractObjectivesNon–small cell lung cancer with mediastinal lymph node involvement is a heterogene...
Objectives: The surgical outcome of pathologic N1 disease in resectable, non-small cell lung carcino...
AbstractObjectivesTo test the hypothesis that patients with non–small cell lung cancer and single-le...
Abstract Background The aim of this study was to determine the prognostic value of lymph node status...
Introduction:This retrospective study was conducted to evaluate the prognostic significance of the n...
Background: patients with IIIA-N2 non-small cell lung cancer represent a large and heterogeneous gro...
The role of positive lymph node location in non-small-cell lung cancer (NSCLC) patients and effects ...
Background: Prognostic factors in patients with single mediastinal station (sN2) involvement continu...
AbstractBackground: The number of N2 stations (single vs multiple N2 stations) is an important progn...
Patients with stage IIIA-ipsilateral mediastinal lymph node involvement (N2) non–small cell lung can...
Currently the most important prognostic factor in lung cancer is the stage. In the current lung TNM ...
To clarify the prognostic implication of the location and number of the metastatic mediastinal nodes...
Patients with non-small cell lung cancer (NSCLC) with metastases to ipsilateral mediastinal lymph no...
AbstractBackground: Clinical trials dealing with multimodal strategy for N2 non–small cell lung canc...
STUDY OBJECTIVES: Accurate TNM staging is the basis to evaluate prognosis and to plan treatment of p...
AbstractObjectivesNon–small cell lung cancer with mediastinal lymph node involvement is a heterogene...
Objectives: The surgical outcome of pathologic N1 disease in resectable, non-small cell lung carcino...
AbstractObjectivesTo test the hypothesis that patients with non–small cell lung cancer and single-le...
Abstract Background The aim of this study was to determine the prognostic value of lymph node status...
Introduction:This retrospective study was conducted to evaluate the prognostic significance of the n...
Background: patients with IIIA-N2 non-small cell lung cancer represent a large and heterogeneous gro...
The role of positive lymph node location in non-small-cell lung cancer (NSCLC) patients and effects ...
Background: Prognostic factors in patients with single mediastinal station (sN2) involvement continu...
AbstractBackground: The number of N2 stations (single vs multiple N2 stations) is an important progn...
Patients with stage IIIA-ipsilateral mediastinal lymph node involvement (N2) non–small cell lung can...
Currently the most important prognostic factor in lung cancer is the stage. In the current lung TNM ...